跳至主要内容
临床试验/NL-OMON50279
NL-OMON50279已完成不适用

Cross-sectional study on peripheral and intrahepatic immune cells derived from chronic hepatitis B patients not on treatment - HBV-FNAB study

Stichting Leveronderzoek0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - man or woman, age of ><=18 and <<= 70 years
  • - chronic Hepatitis B (HBsAg positive for minimum 6 months)
  • - no evidence of cirrhosis
  • - HBV Genotype A, B, C, D or E
  • - otherwise healthy and medically stable
  • - written informed consent
  • - not on treatment for CHB
  • - disease stage specific ALT, HBeAg and HBV DNA (according to protocol)

排除标准

  • - positive HIV test
  • - hepatitis A, C, D or E co-infection
  • - decompensated cirrhosis or hepatocellular carcinoma (documented medical
  • - participation in another translational research study or clinical study
  • - use of any investigational drug or use of an invasive investigational medical
  • device within 90 days before screening
  • - any condition for which, in the opinion of the investigator, participation
  • would not be in the best interest of the subject
  • - major surgery (e.g. requiring general anaesthesia) within 12 weeks before
  • - history of drug or alcohol abuse within 1 year before screening

研究者

发起方
Stichting Leveronderzoek

相似试验